| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067257 Pharmaceutical formulation |
| 04/08/2004 | US20040067222 Regulation of glucocorticoid concentration |
| 04/08/2004 | CA2499818A1 Compositions for the inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases |
| 04/08/2004 | CA2498423A1 Combination drug |
| 04/07/2004 | EP1405861A2 Analogs of parathyroid hormone |
| 04/07/2004 | EP1405636A1 Function regulator for retinoid relative receptor |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404701A1 Method for preparing oestrogen derivatives |
| 04/07/2004 | EP1404682A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 04/07/2004 | EP1404654A2 Calcilytic compounds |
| 04/07/2004 | EP1404649A1 New phenylalkyloxy-phenyl derivatives |
| 04/07/2004 | EP1404516A2 Microencapsulation of drugs by solvent exchange |
| 04/07/2004 | EP1404361A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404357A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 04/07/2004 | EP1404355A1 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404344A2 Bone anabolic compounds and methods of use |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404309A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 04/07/2004 | EP1404308A1 Treatment of disorders secondary to organic impairments |
| 04/07/2004 | EP1086077B1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 04/07/2004 | CN1487950A Androgenic 7-substituted 11-halogen steroids |
| 04/07/2004 | CN1487934A 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1486698A Solid oral preparation containing melbine and Glibenclamide |
| 04/07/2004 | CN1144804C Benzo[C] quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 04/06/2004 | US6716880 Function as sulfatase and/or blocking estrogen receptors; prophylaxis and therapy |
| 04/06/2004 | US6716865 Benzoxa- and benzthiazoles |
| 04/06/2004 | US6716430 Moderating immunology response |
| 04/06/2004 | US6716427 Method for treating hypocalcemia |
| 04/01/2004 | WO2004027421A2 Adp assay |
| 04/01/2004 | WO2004026810A1 Tricyclo[6.2.2]dodeca-2(7),3,5-trien-4-carbonyl)amino]-derivatives having rar-alpha- receptor selective biological activity |
| 04/01/2004 | WO2004026322A1 Method and preparation for preventing casualty caused by iodine radionuclides and optimising iodine metabolism in a postprophylaxis period |
| 04/01/2004 | WO2004005881A3 Methods for identification of compounds modulating insulin resistance |
| 04/01/2004 | WO2003101932A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/01/2004 | WO2003084943A3 Terphenyl derivatives, preparation thereof, compositions containing same |
| 04/01/2004 | WO2003067221A3 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/01/2004 | WO2003056029A3 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate |
| 04/01/2004 | WO2003026635A3 Improved method of treating the syndrome of type 2 diabetes in humans |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063781 Compounds active at the glucocorticoid receptor II |
| 04/01/2004 | US20040063780 Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetes |
| 04/01/2004 | US20040063692 Bazedoxifene treatment regimens |
| 04/01/2004 | US20040063687 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | US20040063661 Treatment of statin side effects |
| 04/01/2004 | US20040063647 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 04/01/2004 | US20040063621 Heterocarpine, a human ghrh-binding protein |
| 04/01/2004 | US20040062794 Flexible backing; adhesive coating; transdermal supplying; reducing triglyceride concentration; sustained release |
| 04/01/2004 | US20040062724 Thin, flexible, multilayer film; applying, adhesion to teeth; supplying active materials |
| 04/01/2004 | US20040061039 Furnace mount and method of installation |
| 04/01/2004 | DE10244453A1 Hemmung der Proteinkinase C-alpha zur Behandlung von Krankheiten Inhibition of protein kinase C-alpha for the treatment of diseases |
| 03/31/2004 | EP1403270A1 Pde iv inhibitors |
| 03/31/2004 | EP1403256A1 Fused imidazole derivative |
| 03/31/2004 | EP1402913A1 Dry powder inhalation system for transpulmonary administration |
| 03/31/2004 | EP1402893A1 Pharmaceutical compositions for treatment of secondary hyperparathyroidism and therapeutic agents for cardiovascular complications resulting from the treatment for secondary hyperparathyroidism. |
| 03/31/2004 | EP1402267A1 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/31/2004 | EP1402266A2 Determination of risk and treatment of complications of prematurity |
| 03/31/2004 | EP1402018A1 Unigene unidirectional antisense library |
| 03/31/2004 | EP1402017A1 Random gene unidirectional antisense library |
| 03/31/2004 | EP1401870A2 Antibodies against tumor necrosis factor delta (april) |
| 03/31/2004 | EP1401863A1 Somatostatin-dopamine chimeric analogs |
| 03/31/2004 | EP1401831A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
| 03/31/2004 | EP1401822A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 03/31/2004 | EP1401801A1 Selective androgen receptor modulators and methods of use thereof |
| 03/31/2004 | EP1401485A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 4-(2- 4-methane sulfonyl oxyphenyl ethoxy)phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and insulin |
| 03/31/2004 | EP1401476A2 Igf antagonist peptides |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone |
| 03/31/2004 | EP1401446A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 03/31/2004 | EP1401441A2 Allosteric adenosine receptor modulators |
| 03/31/2004 | EP1401431A2 Human growth hormone antagonists |
| 03/31/2004 | EP1401427A2 Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them |
| 03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
| 03/31/2004 | EP1401410A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 03/31/2004 | EP1401408A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot |
| 03/31/2004 | EP1401268A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 03/31/2004 | EP1250156A4 Method for nucleic acid transfection of cells |
| 03/31/2004 | EP1025098B1 Benzothiophenes |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486195A Methods for reducing chronic stress in mammals |
| 03/31/2004 | CN1486192A Binding domain-immunoglobulin fusion proteins |
| 03/31/2004 | CN1485048A Medication composition facilitating insulin synthesis, enhancing ATP synthesis, improving immune competency< |
| 03/31/2004 | CN1143847C Thio-oxindole derivatives |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713293 Encapsulated cells containing an amplified expression vector as a drug delivery device |